Product Information
CLENPIQ 175 ML SOLUTION is a brand product labeled by Ferring Pharmaceuticals Inc., priced at $0.5179 per ML under NDC 55566680001. Its NADAC has been published 172 times since Jun 21, 2023.
FDA first approved this application on Nov 28, 2017.
Strength
12; 3.5; 10 g/175mL; g/175mL; mg/175mL
Manufacturer
Ferring Pharmaceuticals Inc.NDC
55566680001
Classification
Brand
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ANHYDROUS CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATEApproval Type
New Drug (NDA)
FDA Application
NDA209589FDA Approved
11/28/2017
On Market Since
3/29/2023
Pharmacological Classes
Price Statistics
The NADAC for CLENPIQ 175 ML SOLUTION has been published 172 times since Jun 21, 2023, and over the history we have for it it has risen 13.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5179 per ML |
|---|---|
| All-time high | $0.5188 (Sep 16, 2026) |
| All-time low | $0.4556 (Jun 21, 2023) |
| 52-week high | $0.5188 |
| 52-week low | $0.4983 |
| Median price | $0.4979 |
| Average price | $0.4910 |
| Largest weekly change | +5.5% (Dec 27, 2023) |
| Weeks tracked | 172 |
| Tracking since | Jun 21, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ferring Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-coagulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLENPIQ 175 ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for CLENPIQ 175 ML SOLUTION, manufactured by Ferring Pharmaceuticals Inc., is $0.5179 per ML (NDC 55566680001), effective Sep 30, 2026.
How has the price of CLENPIQ 175 ML SOLUTION changed over time?
Over the history we have for it, the NADAC for CLENPIQ 175 ML SOLUTION has risen 13.7%. It has been tracked across 172 weekly CMS publications since Jun 21, 2023.
What are the highest and lowest recorded NADAC prices for CLENPIQ 175 ML SOLUTION?
Since Jun 21, 2023, the NADAC for CLENPIQ 175 ML SOLUTION has ranged from a low of $0.4556 (Jun 21, 2023) to a high of $0.5188 (Sep 16, 2026), with a median of $0.4979 per ML.
Are there cheaper alternatives to CLENPIQ 175 ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of CLENPIQ 175 ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLENPIQ 175 ML SOLUTION?
CLENPIQ 175 ML SOLUTION (NDC 55566680001) is labeled by Ferring Pharmaceuticals Inc., and CMS classifies it as a brand product.